Literature DB >> 1589856

Issues in the epidemiology and population-based screening of primary angle-closure glaucoma.

N Congdon1, F Wang, J M Tielsch.   

Abstract

Among Caucasians, it is well known that 75-95% of primary glaucoma is due to open-angle glaucoma (POAG), with angle-closure (PACG) comprising only a very small minority of cases. These figures are reversed among other groups such as Asians and Eskimos, where PACG makes up 80-90% of primary glaucoma. Among Eskimos, the prevalence of PACG has been reported as 2-8%, as compared to 0.1% among Caucasians. It appears that a population tendency toward shallow anterior chambers may explain the excess burden of PACG morbidity. Among Asians, the prevalence of PACG is intermediate between Caucasians and Eskimos. Existing biometrical data do not show a clear tendency toward shallower anterior chambers among Asians. PACG may be screened for on a population basis by means of various techniques that estimate axial or limbal anterior chamber depth, measure intraocular pressure, or evaluate the optic disc or visual fields. Demographic information and medical and family history will also be of great importance in screening for PACG in large populations. Groups at increased risk for the disease include women, individuals over 50, first-degree relatives of PACG probands, and hyperopes.

Entities:  

Mesh:

Year:  1992        PMID: 1589856     DOI: 10.1016/s0039-6257(05)80022-0

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  67 in total

1.  Biometric gonioscopy and the effects of age, race, and sex on the anterior chamber angle.

Authors:  N G Congdon; P J Foster; S Wamsley; J Gutmark; W Nolan; S K Seah; G J Johnson; A T Broman
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

Review 2.  Number of people with glaucoma worldwide.

Authors:  H A Quigley
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

3.  Diurnal intraocular pressure changes in eyes affected with acute primary angle closure and fellow eyes after laser peripheral iridotomy.

Authors:  Han Seok Park; Joon Mo Kim; Seong Hee Shim; Hyun Tae Kim; Jeong Hun Bae; Chul Young Choi; Ki Ho Park
Journal:  Jpn J Ophthalmol       Date:  2015-08-04       Impact factor: 2.447

4.  Normative database of retinal nerve fiber layer and macular retinal thickness in a Thai population.

Authors:  Anita Manassakorn; Winai Chaidaroon; Somsanguan Ausayakhun; Soontaree Aupapong; Sopa Wattananikorn
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

Review 5.  Glaucoma management: relative value and place in therapy of available drug treatments.

Authors:  Deepak Sambhara; Ahmad A Aref
Journal:  Ther Adv Chronic Dis       Date:  2014-01       Impact factor: 5.091

6.  The biometric study in different stages of primary angle-closure glaucoma.

Authors:  Y-Y Chen; Y-Y Chen; S-J Sheu; P Chou
Journal:  Eye (Lond)       Date:  2013-06-21       Impact factor: 3.775

7.  Ability of non-ophthalmologist doctors to detect eyes with occludable angles using the flashlight test.

Authors:  Carolina Pelegrini Barbosa Gracitelli; Bruno Landgren; Flávia Bracale Graciani; Aline Kátia Siqueira Sousa; Augusto Paranhos; Tiago Santos Prata
Journal:  Int Ophthalmol       Date:  2013-10-01       Impact factor: 2.031

8.  Outcomes of effective goniosynechialysis under an endoscopic view combined with phacoemulsification in residual angle-closure glaucoma with lens opacity: 6-month results.

Authors:  Wei Tang; Zhengwei Zhang; Yujie Zhang; Xiaolei Yin; Yinong Zhang; Qianqian Li
Journal:  Int Ophthalmol       Date:  2020-07-31       Impact factor: 2.031

9.  Five year risk of progression of primary angle closure suspects to primary angle closure: a population based study.

Authors:  R Thomas; R George; R Parikh; J Muliyil; A Jacob
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

10.  Age, gender, biometry, refractive error, and the anterior chamber angle among Alaskan Eskimos.

Authors:  Robert Wojciechowski; Nathan Congdon; William Anninger; Aimee Teo Broman
Journal:  Ophthalmology       Date:  2003-02       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.